RT Journal Article
SR Electronic
T1 The Peruvian Genome Project: expanding the global pool of genome diversity from South America
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.05.24306840
DO 10.1101/2024.05.05.24306840
A1 Guio, Heinner
A1 Caceres, Omar
A1 Sanchez, Cesar
A1 Padilla, Carlos
A1 Trujillo, Omar
A1 Borda, Victor
A1 Jaramillo-Valverde, Luis
A1 Poterico, Julio A.
A1 Silva-Carvalho, Carolina
A1 Horton, Mary
A1 Lanata, Cristina M
A1 Carnevale, Alessandra
A1 Romero-Hidalgo, Sandra
A1 Canizales-Quinteros, Samuel
A1 Acuña-Alonzo, Víctor
A1 Machacuay-Romero, Marco
A1 Novoa, Pedro
A1 Frisancho, Roberto
A1 Shady, Ruth
A1 Flores-Villanueva, Pedro
A1 O’Connor, Timothy D.
A1 Corpas, Manuel
A1 Tarazona-Santos, Eduardo
YR 2024
UL http://medrxiv.org/content/early/2024/08/07/2024.05.05.24306840.abstract
AB The process of inhabiting the Americas by ancestral native American populations involved many individuals settling in the Peruvian Andes and Amazonian regions. Due to Latin American countries representing less than 1% of the human genome data available in public reference databases, the evolution and migration processes involved in adapting to this unique geography have not yet been fully explained. The Peruvian Genome Project is an initiative, started in 2011, to address the underrepresentation of genomic data from native South American populations. This project has collected 1,149 samples from 17 traditional native and 13 mestizo (mixed of native, African, and European ancestry) communities. Currently, 150 whole genomes and 873 array-genotyped individuals have been sequenced from across the geography of Western South America, including coastal, Andes, and Amazonian regions. We discovered 1.6 million novel genetic variants with varying frequencies, indicative of local environmental adaptations and population drift. These novel variants allow us to infer local evolutionary traits and population-specific allele frequencies for people living at different altitudes, as well as varying adaptations to pathogens and living conditions. The Peruvian Genome Project is the result of over a decade of work in sample selection, logistics, and approved regulatory community engagement, designed to enhance the human genome pool of diversity of native Americans. The data collected here enable the targeted characterization of endemic diseases, trait adaptations, and new variants of clinical significance in South America. The Peruvian Genome Project represents a step forward in international and multidisciplinary efforts to make precision medicine more inclusive and accessible for underrepresented communities in Latin America, offering significant potential for drug development and diagnostics in a neglected continent.Competing Interest StatementAt the time of writing MC declares he is associated with Cambridge Precision Medicine Limited. HG declares he worked at the Instituto Nacional de Salud until June, 2020 and now is associated as Medical Director in INBIOMEDIC Research and Technological Center. No other author involved in this publication declares any further conflict of interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research and Ethics Committee from the Instituto Nacional de Salud (authorization no. OI-003-11 and no. OI-087-13).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes